Verzenio Plus Faslo...
 

Verzenio Plus Faslodex Improves Overall Survival by 9 Months in Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer  

  RSS

johan
(@johan)
New Member
Joined: 1 year ago
Posts: 88
07/10/2019 1:24 pm  

"The CDK4/6 inhibitor Verzenio (chemical name: abemaciclib) in combination with the hormonal therapy Faslodex (chemical name: fulvestrant) offered better overall survival — about 9 months longer — than Faslodex alone in women diagnosed with advanced-stage, hormone-receptor-positive, HER2-negative breast cancer"

https://www.breastcancer.org/research-news/verzenio-plus-faslodex-improves-overall-survival


Daniel liked
Quote
Topic Tags
Share: